Evidence map›Paper›PMID 40983145›Full record

ArticleAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2026

Urine Oxalate Excretion and CKD Stage in Patients With Primary Hyperoxaluria Type 1.

Lisa E Vaughan, Phillip J Schulte, Felix Knauf, David J Sas, Dawn S Milliner, John C Lieske

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lisa E VaughanDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.
Phillip J SchulteDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.
Felix KnaufDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
David J SasDivision of Pediatric Nephrology, Mayo Clinic, Rochester, Minnesota; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
Dawn S MillinerDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota; Division of Pediatric Nephrology, Mayo Clinic, Rochester, Minnesota.
John C LieskeDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. Electronic address: Lieske.John@mayo.edu.

Funding

Primary HyperoxaluriaU54DK083908 · NIDDK · MAYO CLINIC ROCHESTER · PI MILLINER, DAWN SCHMAUTZ · 2009 to 2018
$12.3M
VISUALIZATION AND PATHOPHYSIOLOGY OF RENAL STONE PRECURSOR LESIONSU54DK100227 · NIDDK · MAYO CLINIC ROCHESTER · PI LIESKE, JOHN C · 2013 to 2017
$6.3M
An individualized medicine approach to urinary stone diseaseR01DK133171 · NIDDK · MAYO CLINIC ROCHESTER · PI Peter C. Harris, Felix Knauf · 2022 to 2026
$3.0M
Research ProjectP20DK135097 · NIDDK · MAYO CLINIC ROCHESTER · PI LIESKE, JOHN C · 2022 to 2024
$1.2M
NIDDK NIH HHS P20 DK135097NIDDK NIH HHS R01 DK133171NIDDK NIH HHS U54 DK083908NIDDK NIH HHS U54 DK100227
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40983145
PMCPMC12462907

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.